7 completed, 5 recruiting, 5 unknown, 2 active not recruiting. 20 Phase 2, 6 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 20 | Completed 7, Recruiting 5, Unknown 5, Active not recruiting 2, Suspended 1 |
| Phase 1 | 6 | Completed 3, Recruiting 1, Suspended 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Fluid Therapy: new trials by email Literature Review of Fluid Therapy trials Research Report on Fluid Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment Lidocaine (drug), Saline - Refractory Migraine, Headache | Phase 2 | Recruiting | Daniel A Tonetti, MD | 80 | 2026-09-09 | 2026-10-01 |
| EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES Melatonin, intravenous (IV) fluids, intensive monitoring, broad-spectrum antibiotic cover - Hypoxic Ischaemic Encephalopathy (HIE) | Phase 2 | Active not recruiting | University of Child Health Sciences and Children's Hospital, Lahore | 110 | 2025-12-10 | 2025-12-26 |
| Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases Biospecimen Collection, Bone Marrow Aspirate, Cyclophosphamide - Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 54 | 2024-07-23 | 2026-10-26 |
| Early Resuscitation in Paediatric Sepsis Using Inotropes Fluid, Adrenalin - Sepsis | Phase 2 | Unknown | NATALIA LOPERA MUNERA | 40 | 2024-07-01 | 2024-06-27 |
| Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma Belantamab Mafodotin, Biospecimen Collection, Bone Marrow Aspirate - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Recruiting | Mayo Clinic | 62 | 2024-01-04 | 2026-07-14 |
| CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Diffuse Midline Glioma, H3 K27-Altered, Metastatic Malignant Neoplasm in the Central Nervous System | Phase 1 / Phase 2 | Recruiting | Children's Oncology Group | 63 | 2022-01-28 | 2026-09-11 |
| Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Marine liquid and fluids, Impregnation, Incubation - Coronavirus Infections, Coronavirus Sars-Associated | Phase 2 | Unknown | Universidade do Porto | 45 | 2021-10-01 | 2022-04-15 |
| Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants Vigabatrin, Rapamycin, Placebo - Tuberous Sclerosis Complex | Phase 2 / Phase 3 | Recruiting | Katarzyna Kotulska | 60 | 2021-05-07 | 2026-10-22 |
| Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 288 | 2018-09-27 | 2026-10-22 |
| The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence Intravesical 2000mg/52.6ml gemcitabine instillation, Normal saline - Urothelial Carcinoma | Phase 2 | Unknown | National Cancer Center, Korea | 134 | 2018-03-01 | 2022-04-14 |
| Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients Ergocalciferol 8000 IU/ML Oral Liquid [DRISDOL], Propylene Glycol - Vitamin D Deficiency, Polytrauma | Phase 1 / Phase 2 | Suspended | New York City Health and Hospitals Corporation | 60 | 2017-07-01 | 2019-04-04 |
| Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women Strath® Kräuterhefe Original (liquid) - Overweight | Phase 1 / Phase 2 | Completed | Bio-Strath AG | 26 | 2017-05-11 | 2024-08-26 |
| Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis HIZENTRA ® - Myasthenia Gravis | Phase 2 | Completed | Mazen Dimachkie, MD | 23 | 2015-05-01 | 2021-06-02 |
| Multiple Treatments for Ebola Virus Disease (EVD) Azithromycin, Sunitinib and Erlotinib, Atorvastatin and Irbesartan - Ebola Virus Disease | Phase 1 / Phase 2 | Unknown | Clinical Research Management, Inc. | 150 | 2015-04-01 | 2015-03-05 |
| A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma Bendamustine, Obinutuzumab, Polatuzumab vedotin (Liquid) - Lymphoma | Phase 1 / Phase 2 | Completed | Hoffmann-La Roche | 331 | 2014-10-15 | 2022-11-14 |
| Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler adenosine + dipyridamole - Ischemic Heart Disease | Phase 2 | Unknown | Adenobio N.V | 75 | 2011-06-01 | 2012-09-07 |
| Hsv 1 and 2 Gowey Protocol Versus Placebo Versabase gel with sarracenia purpurea 20% liquid extract, placebo (versabase gel only) - Herpes | Phase 1 / Phase 2 | Completed | Naturopaths International | 33 | 2011-01-01 | 2011-11-23 |
| Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4 Fu-zheng-qu-zhuo (FZQZ) oral liquid - Stage 3 Chronic Kidney Disease, Stage 4 Chronic Kidney Disease | Phase 2 | Completed | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 124 | 2010-06-01 | 2014-10-27 |
| Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage Diagnostic peritoneal lavage - Gastric Cancer, Pancreatic Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 112 | 2010-05-01 | 2019-06-14 |
| Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T) CAIV-T, Liquid - Influenza | Phase 2 | Completed | MedImmune LLC | 60 | 2001-09-01 | 2021-09-13 |
Lymphoma (2) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · COVID-19 (1) · Carcinoma, Endometrioid (1) · Carcinoma, Transitional Cell (1) · Carcinosarcoma (1) · Coronavirus Infections (1) · Diffuse Intrinsic Pontine Glioma (1) · Emergencies (1) · Epilepsy (1) · Headache (1) · Hemorrhagic Fever, Ebola (1) · Herpes Simplex (1) · Hypoxia-Ischemia, Brain (1) · Influenza, Human (1)
Adenobio N.V (1) · Bio-Strath AG (1) · Children's Oncology Group (1) · Clinical Research Management, Inc. (1) · Daniel A Tonetti, MD (1) · Fred Hutchinson Cancer Center (1) · Guang'anmen Hospital of China Academy of Chinese Medical Sciences (1) · Hoffmann-La Roche (1) · Katarzyna Kotulska (1) · Mayo Clinic (1) · Mazen Dimachkie, MD (1) · MedImmune LLC (1) · Memorial Sloan Kettering Cancer Center (1) · NATALIA LOPERA MUNERA (1) · National Cancer Center, Korea (1)
United States (11) · Canada (3) · Australia (2) · France (2) · South Korea (2) · Argentina (1) · Bolivia (1) · China (1) · Czechia (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · Pakistan (1) · Paraguay (1)
Ann Dahlberg (1) · Christopher Woods, MD, MPH (1) · David L Hoover, MD (1) · David S Ziegler (1) · Helen J Mackay (1) · Jie Wang (1) · John M Griffiss, MD (1) · Jorge P Machado, PhD (1) · Katarzyna Kotulska-Jozwiak (1) · Mazen M Dimachkie, MD (1) · Milan Sen, MD (1) · Muhammad Khalid Masood, MBBS, FCPS (1) · Patrick Meimoun, PhD (1) · Peter W. Joller, PhD (1)
PMID 26768569, PMID 31693429, PMID 32705923, PMID 32770353, PMID 33028076, PMID 34749395, PMID 35086141, PMID 37981564, PMID 38127487, PMID 38843483
2014 (1), U10CA180868 (1), UM1CA228823 (1)